February 23, 2021, 10:46 am EST
2021 Actual Trade: NVAX +122% Profits
COVID-19 was definitely a hot topic for 2020. Various vaccines and treatments made biotech and pharmaceuticals busy and popular. We mentioned NVAX many times in the past:
11/27/2020 Stock Market Today:
https://marketfellow.com/2020/11/27/stock-market-today-vaccine-candidates/
12/14/2020 Stock News:
https://marketfellow.com/2020/12/14/market-news-vaccine-approval/
02/04/2021 Stock Picks
https://marketfellow.com/2021/02/04/stock-picks-covid-19-vaccine-novavax-inc-nvax/
NVAX provides desirable sideway patterns both from September-November 2020 and December-January 2021 so it gave us a chance to study NVAX from technical and fundamental perspectives.
After we accumulated twice in January 2021, NVAX was discovered and shot to the sky. We took a quick profit first. Then, COVID-19 began to decline, which caused NVAX to slow down also. We decided to close it completely. The highest point we got from NVAX was +122% profits.
